Please assess the completion status of the following clinical trial:

Trial Title: Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult OAB patients who present with OAB symptoms, including micturitions \>= 8 per day and urgency urinary incontinence \>= 1 per day.~Exclusion Criteria:~* Patient has known hypersensitivity to the active substance (fesoterodine fumarate) or to peanut or soya or any of the excipients.~* Patient has a known neurological disease influencing bladder function.~* Patient has a complication of lower urinary tract pathology potentially responsible for urgency or incontinence, clinically relevant bladder outlet obstruction or pelvic organ prolapse.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fesoterodine fumarate 4 mg (Double-Blind) (Type: EXPERIMENTAL): None
- Placebo (Double-Blind) (Type: PLACEBO_COMPARATOR): None
- Fesoterodine fumarate 8 mg (Double-Blind) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).